XML 214 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net loss $ (19,985) $ (20,840)
Other comprehensive income (loss):    
Available for sale securities - net unrealized gain 1 12
Cumulative translation adjustment arising during the period (40) (25)
Total other comprehensive loss (39) (13)
Comprehensive loss (20,024) (20,853)
Comprehensive income (loss) attributable to noncontrolling interests 0 0
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders $ (20,024) $ (20,853)